Israel · Delayed Price · Currency is ILS · Price in ILA NewMed Energy - Limited Partnership Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw lower revenues and near-zero net profit due to a month-long shutdown, but full-year guidance was raised by $330 million on higher Brent prices and increased production capacity. Major pipeline projects and new market agreements are set to boost future growth.
Fiscal Year 2025
-
Q1 2026 results were impacted by a major shutdown, leading to lower revenues and net profit, but higher Brent prices and increased production capacity are expected to drive a $330 million upside for the year. Major infrastructure and export agreements support future growth.
-
Q2 2025 saw lower revenue and profit due to production halts and lower prices, but a major new gas deal and ongoing expansion projects support future growth. Dividend distributions continue, and exploration in Bulgaria could drive further upside.
-
Q1 2025 saw natural gas sales rise to 2.9 BCM and revenues reach $288 million, with net profit at $116 million. Major infrastructure and exploration projects advanced, and a $60 million dividend plus $400 million bond prepayment were announced.
Fiscal Year 2024
-
2024 saw record production and a 21% rise in net income to $525 million, with revenues at $1.14 billion. Major expansion projects and new export agreements are underway, while dividends and debt reduction remain priorities.
-
Record Q3 results with net profit up 25% year-over-year, driven by higher Leviathan production and sales. Major infrastructure projects are progressing, though some face delays, and the company maintains a strong balance sheet with ongoing dividend payouts.
-
Q2 saw a 47% year-over-year net profit increase to $137 million, with sales volumes and prices rising due to strong demand in Egypt and Israel. Expansion projects are on track, and a $65 million dividend was declared, supported by reduced debt and robust cash flow.